Skip to content
Search

Latest Stories

State of Pharmacy 2020: fearful of changes on the horizon, pharmacists expect more store closures

An overwhelming majority of pharmacists expect more pharmacy closures in 2020, according to a recent survey.

A total of 93 per cent of those who responded to a National Pharmacy Association-supported survey said they believe it is not a good time to open a pharmacy.


The State of Pharmacy 2020 report by Medicspot shows that 80 per cent pharmacists are fearful about the changes on the horizon.

Almost 60 per cent of them viewed gross margins being squeezed as the biggest threat this year, followed by adapting to the new five-year NHS pharmacy contract and competition from online pharmacies.

Worries over Brexit and medicine supply were also weighing on pharmacists across the UK.

Mark Lyonette, CEO of the NPA, said: “Many pharmacies are struggling because of a combination of squeezed funding, medicines shortages and inflated prices. Funding is not keeping pace with escalating costs".

"Maintaining cash flow is a problem for a lot of independents in these circumstances. But pharmacists are trusted professionals and community pharmacies provide an excellent service that patients need and value. This underpins our confidence that there is a commercially viable and professionally rewarding long term future for the sector,” Lyonette said.

In 2020, pharmacists hope to dispense more private prescriptions and 82 per cent are also interested in offering private doctor consultations from their pharmacy.

Over 81 per cent have plans to offer prescription delivery this year, of which eight in ten said they would offer it for free.

The survey further revealed that the majority of the pharmacists still consider online dispensing as a threat rather than an opportunity though they are aware of the importance of having an online presence.

“Pharmacies are offering services such as free home delivery in an attempt to preserve market share. They have to compete with not only community pharmacies, but also online pharmacies who offer free delivery. Hence, I don't see the trend of offering free delivery reversing, but it might be beneficial for pharmacy owners to look at the economics of offering the service – higher script volume doesn't always filter down to the bottom line.” said Dr Zubair Ahmed, CEO of Medicspot.

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
It is official: Opella is now a standalone company

Opella launches as an independent company to redefine the future of self-care.

Photo credit: gettyimages

Opella becomes standalone company as Sanofi-CD&R deal closes

Opella has officially become a standalone company, following the completion of Sanofi’s sale of a controlling 50.0% stake to private equity firm Clayton, Dubilier & Rice (CD&R).

Sanofi retains a significant shareholding with a 48.2% stake while Bpifrance holds the remaining 1.8% stake.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less